April 25, 2018 / 12:10 PM / 3 months ago

BRIEF-Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform To Daré Bioscience

April 25 (Reuters) - Juniper Pharmaceuticals Inc:

* JUNIPER PHARMACEUTICALS LICENSES INTRAVAGINAL RING (IVR) PLATFORM TO DARÉ BIOSCIENCE

* JUNIPER PHARMACEUTICALS - ELIGIBLE TO RECEIVE UP TO $43.75 MILLION IN MILESTONES FOR EACH IVR CANDIDATE, PLUS ROYALTIES ON FUTURE SALES

* JUNIPER PHARMACEUTICALS - UNDER AGREEMENT, DARÉ TO BE RESPONSIBLE FOR CONDUCTING ALL RESEARCH, DEVELOPMENT, AND COMMERCIAL ACTIVITIES FOR PROGRAM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below